EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Association between geniquin therapy and the risk of developing periodontal disease in patients with primary Sjögren’s syndrome: A population-based cohort study from Taiwan

Chun-Yuan Chiu, Da-Yo Yuh, Li-Chyun Yeh, Iau-Jin Lin, Chi-Hsiang Chung, Chung-Hsing Li iD, Wu-Chien Chien, Gunng-Shinng Chen

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0305130 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Chun-Yuan Chiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics and Pediatrics Dentistry, Tri-Service General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Periodontal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease that causes dysfunction of salivation and harmful oral conditions. The association between periodontal disease (PD) and pSS with or without geniquin therapy remains controversial. This study evaluated the association between geniquin therapy and the risk of subsequent development of PD in pSS patients. From Taiwan’s National Health Insurance Research Database, we selected a control cohort of 106,818 pSS patients, followed up from 2000 to 2015, matched (1:4) by age and index year with 427,272 non-pSS patients. We also analyzed 15,149 pSS patients receiving geniquin therapy (cohort 1) and 91,669 pSS patients not receiving geniquin therapy (cohort 2). After adjusting for confounding factors, multivariate Cox proportional hazards regression analysis was used to compare the risk of PD over the 15-year follow-up. In the control cohort, 11,941 (11.2%) pSS patients developed PD compared to 39,797 (9.3%) non-pSS patients. In cohorts 1 and 2, 1,914 (12.6%) pSS patients receiving geniquin therapy and 10,027 (10.9%) pSS patients not receiving geniquin therapy developed PD. The adjusted hazard ratio (HR) for subsequent PD in pSS patients was 1.165 (95% confidence interval [CI] = 1.147–1.195, p < 0.001) and in pSS patients receiving geniquin therapy was 1.608 (95% CI = 1.526–1.702, p < 0.001). The adjusted HR for PD treatment was 1.843. Patients diagnosed with pSS showed an increased risk of developing subsequent PD and receiving PD treatment than patients without pSS, while pSS patients receiving geniquin therapy showed even higher risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromePeriodontal DiseasesHumansTaiwanFemaleMaleMiddle AgedAdultCohort StudiesAgedRisk FactorsProportional Hazards Models

Autor:innen und Institutionen

  • Department of Orthodontics and Pediatrics Dentistry, Tri-Service General Hospital, Taipei, Taiwan.
  • School of Dentistry, National Defense Medical Center, Taipei, Taiwan.
  • Department of Periodontology, Tri-Service General Hospital, Taipei, Taiwan.
  • School of Early Childhood Care and Education, University of Kang-Ning, Taipei, Taiwan.
  • Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
  • School of Public Health, National Defense Medical Center, Taipei, Taiwan.

ORCID-Profile: Chung-Hsing Li

Förderung

  • Tri-Service General Hospital

Zitieren

APA

Chiu, C. Y., Yuh, D. Y., Yeh, L. C., Lin, I. J., Chung, C. H., Li, C. H., Chien, W. C., & Chen, G. S. (2024). Association between geniquin therapy and the risk of developing periodontal disease in patients with primary Sjögren’s syndrome: A population-based cohort study from Taiwan. PLOS ONE. https://doi.org/10.1371/journal.pone.0305130

Vancouver

Chiu CY, Yuh DY, Yeh LC, Lin IJ, Chung CH, Li CH, et al. Association between geniquin therapy and the risk of developing periodontal disease in patients with primary Sjögren’s syndrome: A population-based cohort study from Taiwan. PLOS ONE. 2024. doi:10.1371/journal.pone.0305130

BibTeX
@article{Chiu2024,
  author = {Chiu, Chun-Yuan and Yuh, Da-Yo and Yeh, Li-Chyun and Lin, Iau-Jin and Chung, Chi-Hsiang and Li, Chung-Hsing and Chien, Wu-Chien and Chen, Gunng-Shinng},
  title = {Association between geniquin therapy and the risk of developing periodontal disease in patients with primary Sjögren’s syndrome: A population-based cohort study from Taiwan},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0305130}
}
Kostenlos starten →